Arvelle Therapeutics Investors

28 investors on Angel Roster list Arvelle Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States, France and the Netherlands.

Investors are matched on the company name in their portfolio, so companies that share the name Arvelle Therapeutics can appear together.

Investors listed
28
With verified email
29%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 28 Arvelle Therapeutics investors

The most complete profiles first. Showing 28 of 28.

  • Olivier LitzkaVerified

    Venture Capital, Private Equity Firm, Investor · Germany

    Series BHealth CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, Noxxon Pharma and 83 more

    Verified email available

  • Jorge RamirezVerified

    Venture Capital · United States

    Health CareHospitalsGeneticsWomen Founded

    Portfolio: Cerephex, Intact Vascular, Orbus Therapeutics, RxSight and 12 more

    Verified email available

  • Michael WassermanVerified

    Venture Capital · United States

    Health CareHospitalsGeneticsWomen Founded

    Portfolio: Cerephex, Intact Vascular, Orbus Therapeutics, RxSight and 12 more

    Verified email available

  • Alexandre Foulon

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesHospitalsDeepTech

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Arnaud Faure

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Drew Burdon

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Martijn Kleijwegt

    Venture Capital, Private Equity Firm, Investor · Netherlands

    Series BHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Mayeul Caron

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Pierre

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Rudy Dekeyser

    Venture Capital, Private Equity Firm, Investor · Belgium

    Series BHealth CareHospitalsLife ScienceMobile

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Vincent Brichard

    Private Equity Firm, Investor · Netherlands

    SeedHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Brian AxeVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Contact details available

  • Christina SmithVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Verified email available

  • John BradleyVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Verified email available

  • Michael SorensenVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Verified email available

  • Patrick JordanVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Verified email available

  • Ryan WootenVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Verified email available

  • Alex Zisson

    Venture Capital · United States

    Health CareHospitalsGeneticsWomen Founded

    Portfolio: Cerephex, Intact Vascular, Orbus Therapeutics, RxSight and 12 more

    Contact details available

  • David Robin

    Venture Capital, Private Equity Firm · France

    Health CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Merijn Klaassen

    Private Equity Firm · Netherlands

    Health CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Pierre Morisseau

    Venture Capital, Private Equity Firm · France

    Health CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Anthony DiNoto

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Contact details available

  • Devin Rosenthal, PhD, MBA

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Contact details available

  • Guy Petrelli

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Contact details available

  • Jeff Edwards

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Contact details available

  • Jonathan Tunnicliffe

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Contact details available

  • Robert Hester, CPA

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Contact details available

  • Vern Davenport

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Roivant Sciences, InformedDNA, Clinical Ink, Mesoblast and 4 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Arvelle Therapeutics investors are on Angel Roster?

Angel Roster lists 28 Arvelle Therapeutics investors. 8 of them (29%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (26) and Private Equity Firms (12). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Arvelle Therapeutics investors invest in?

Among those that list a stage, the most common are Series B (8) and Seed (1).

Where are Arvelle Therapeutics investors based?

Most are based in the United States (16), France (6) and the Netherlands (3).

Which companies have Arvelle Therapeutics investors backed?

The most-backed portfolio companies among them are Clinical Ink (13), Roivant Sciences (13), BioCritica (13), InformedDNA (13) and PreCision Dermatology (13).

How do I contact Arvelle Therapeutics investors?

Create a free Angel Roster account to search and filter all 28, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.